With funding gone, child care owners warn of dire future
A survey estimated 1,000 centers around the state will close -- nearly one in four --and 30,000 more openings will go unfilled. Forty percent anticipate raising tuition 35 percent; 75 percent will have longer waiting lists and 40 percent will have to close some classrooms.
Opinion
How can Democrats win?
Democrats ought to focus on improving the lives of working-class people of all races
Education
JFC Republicans take knife to Evers' public education request
The JFC approved a small increase to the special education reimbursement rate from 33 to 35 percent in budget year one and to 37.5 percent in year two, still only about a third of the reimbursement levels of private schools
With funding gone, child care owners warn of dire future
A survey estimated 1,000 centers around the state will close -- nearly one in four --and 30,000 more openings will go unfilled. Forty percent anticipate raising tuition 35 percent; 75 percent will have longer waiting lists and 40 percent will have to close some classrooms.
Next step in attempt to repeal Act 10 is court of appeals
If the Act 10 challenge is successful, it would restore collective bargaining rights for many public employees in Wisconsin, including teachers, nurses, prison guards, and other state government employees
Politics
JFC Republicans take knife to Evers' public education request
The JFC approved a small increase to the special education reimbursement rate from 33 to 35 percent in budget year one and to 37.5 percent in year two, still only about a third of the reimbursement levels of private schools
How can Democrats win?
Democrats ought to focus on improving the lives of working-class people of all races
Business
ACOCA owner feels uncertainty with Trump's shaky tariff policy
Tariffs on everything from coffee to oat milk to blueberries and avocados impact Acoca’s bottom line. Bill Wetzel says there’s only so much he can do to plan for such things, especially given all the uncertainty.
The Deepest Cut: The looming disaster from the assault on the FDA
With the FDA now woefully understaffed, medical device companies are in limbo with how to proceed on either a new project or a project that is in the end stages but still requires FDA guidance and approval.
